Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma

JAMA Oncol. 2017 May 1;3(5):703-704. doi: 10.1001/jamaoncol.2016.6611.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Headache / chemically induced
  • Headache / drug therapy*
  • Humans
  • Hydrocortisone / therapeutic use
  • Hypophysitis / chemically induced*
  • Hypophysitis / diagnostic imaging
  • Hypophysitis / drug therapy
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Ipilimumab / administration & dosage
  • Magnetic Resonance Imaging
  • Melanoma / pathology
  • Melanoma / therapy*
  • Middle Aged
  • Nivolumab / administration & dosage

Substances

  • Ipilimumab
  • Nivolumab
  • Hydrocortisone